Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Friday newspaper round-up: Archbishop of Canterbury, AstraZeneca, Scotland

Fri, 25th Apr 2014 07:17

The Archbishop of Canterbury joined the prime minister in a staunch defence of Christian Britain yesterday, as Nick Clegg called for an end to the link between church and state. The Most Rev Justin Welby said he had found it "quite baffling" to see the vociferous response to David Cameron's "moving" Easter declaration that Britain should be proud of its status as a Christian country. - The Wall Street Journal EuropeTwo of Britain's biggest companies, AstraZeneca and Barclays, were given a public mauling by shareholders over pay and bonuses yesterday as the City's top fund managers threatened to stage a repeat performance of their spring uprising of two years ago. Shareholders speaking for 38.5% of AstraZeneca voted against the remuneration report at the drugs group's annual meeting. - The TimesThe BBC has announced it has suspended its membership of the CBI following the business lobbying organisation's decision to register as a supporter of the No campaign [in Scotland]. A short statement issued by the Corporation said the decision had been taken in conjunction with the CBI in order to protect the public sector broadcaster's neutral political stand-point. - The ScotsmanAn EU tax on financial transactions is set to move closer next week with Britain expected to suffer an embarrassing defeat in its legal attempt to block the move. The levy, pushed by France and Germany, could wipe more than £3.6bn from the value of UK shares and bonds, according to some estimates, and has been described as "deadly" for the financial sector. - The TimesBarclays has become embroiled in a row with one of its biggest investors after being criticised over the bank's decision to increase bonuses last year despite a fall in profits. Sir David Walker, chairman of Barclays, and Sir John Sunderland, head of the bank's remuneration committee, rounded on Standard Life Investments after the fund manager spoke out at the lender's annual shareholder meeting saying it was "unconvinced" of the need to pay such large bonuses. - The Daily Telegraph Amazon, whose shares have dropped sharply in the past three months, announced rapidly growing earnings on Thursday amid a flurry of new initiatives. The company said that its revenue rocketed 23% to $19.74bn in the first three months of this year, compared with $16.07bn at the same time a year ago, above analysts' expectations. - The GuardianAB

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.